| Direct Competitor Comparison | |
|---|
| BMRN | FOLD | PVT1 | SHPG | Industry |
|---|
| Market Cap: | 8.95B | 168.75M | N/A | 18.29B | 71.76B |
|---|
| Employees: | 1,089 | 112 | N/A | 5,367 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.10 | N/A | N/A | -0.01 | 0.27 |
|---|
| Revenue (ttm):
| 512.00M | 10.64M | N/A | 4.67B | 13.93B |
|---|
| Gross Margin (ttm): | 0.81 | -0.66 | N/A | 0.86 | 0.72 |
|---|
| EBITDA (ttm): | -65.17M | -57.71M | N/A | 1.51B | 1.51B |
|---|
| Operating Margin (ttm):
| -0.20 | -5.59 | N/A | 0.26 | 0.13 |
|---|
| Net Income (ttm): | -130.18M | -53.11M | N/A | 571.80M | N/A |
|---|
| EPS (ttm): | -1.05 | -1.10 | N/A | 3.06 | 0.61 |
|---|
| P/E (ttm): | N/A | N/A | N/A | 32.51 | 18.43 |
|---|
| PEG (5 yr expected): | -1.50 | N/A | N/A | N/A | 1.51 |
|---|
| P/S (ttm): | 17.85 | 15.96 | N/A | 3.81 | 3.64 |
|---|
|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.91 | 0.00 | 79.43B | 17.93 |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 235.24 | 0.01 | 55.84B | 37.33 |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 55.81 | 0.01 | 85.13B | 31.25 |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 74.04 | 0.00 | 12.74B | 31.35 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.34 | -0.00 | 33.52B | 19.64 |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.23 | -0.01 | 16.25B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 31.17 | -0.02 | 11.88B | 20.82 |
|---|
| Pfizer Inc. | PFE | 29.04 | -0.00 | 205.99B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.87B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.97 | 0.00 | 128.29B | 19.36 |
|---|
| Sanofi | SNY | 54.86 | 0.01 | 145.20B | 27.04 |
|---|
| Novartis AG | NVS | 74.36 | 0.01 | 182.72B | 18.87 |
|---|
| Roche Holding AG | RHHBY | 65.96 | 0.01 | 223.86B | 22.07 |
|---|
| AstraZeneca PLC | AZN | 52.17 | 0.00 | 65.21B | 11.54 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.86B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.40 | 0.01 | 77.86B | 53.68 |
|---|
|
| News on Direct Competitors | |
|---|
- SHPG
- Shire PLC (SHPG): Today's Featured Health Care Winner at TheStreet Fri 5:00pm
- SHPG
- SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online Thu, May 23
- SHPG
- Positive Data on Roche Candidate Zacks Wed, May 22
- FOLD
- AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online Wed, May 22
- FOLD
- Amicus Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript) at Seeking Alpha Tue, May 21
- SHPG
- The Surprising Link Between ADHD and Obesity at Motley Fool Tue, May 21
- SHPG
- Shire Rises On Unusually High Volume (SHPG) at TheStreet Mon, May 20
- FOLD
- AMICUS THERAPEUTICS INC Financials EDGAR Online Financials Fri, May 17
- FOLD
- Amicus Therapeutics: The Good And The Bad at Seeking Alpha Wed, May 15
- FOLD
- Amicus Therapeutics to Present at UBS Global Healthcare Conference GlobeNewswire Tue, May 14
All Headlines for these symbols... Currency in USD. | |
|
1.37(2.08%) May 24, 4:00PM EDT|After Hours
:
64.39 0.00 (0.00%) May 24, 4:06PM EDT